Brief: Cullinan Oncology Reports First Quarter 2023 Financial Results

Cullinan Therapeutics

11/05/2023 21:46

May 11 (Reuters) - Cullinan Oncology Inc  CGEM.O :
    * CULLINAN ONCOLOGY PROVIDES CORPORATE UPDATE AND REPORTS
FIRST
QUARTER 2023 FINANCIAL RESULTS
    * CASH AND INVESTMENT POSITION OF $503.5 MILLION AS OF MARCH
31,
2023 CONTINUES TO GIVE RUNWAY INTO 2026
    * QTRLY LOSS PER SHARE $1.42
    * Q1 EARNINGS PER SHARE VIEW $-0.98 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX7twwmF 
Further company coverage:  CGEM.O 

 ((Reuters.Briefs@thomsonreuters.com;))